Scott Lippman, MD, is director of the Moores Cancer Center at the University of California San Diego (UCSD), and professor of medicine, senior associate dean, associate vice chancellor for cancer research and care, and Chugai Pharmaceutical Chair at UCSD. Before joining Moores Cancer Center in 2012, he was chair of the Department of Thoracic/Head and Neck Medical Oncology at The University of Texas MD Anderson Cancer Center.
His research interests include cancer interception, and he works closely with computational biologists helping to develop and fund novel, "big-data" analytic approaches to precision medicine and prevention.
Dr. Lippman served as co-chair the National Cancer Institute's Cancer Moonshot Pre-Cancer Atlas (PCA) Demonstration Project. The premise of this moonshot is to develop an integrated multi-omics and immunity PCA – to interrogate, target, and intercept events that drive the formation of cancer.
He has published over 450 peer-reviewed primary research articles, received numerous scientific awards, and has served on the editorial board of several major scientific journals. He is the editor-in-chief of the journal Cancer Prevention Research and was appointed the inaugural chair of the Cancer Prevention Committee of the American Association for Cancer Research.